Epigallocatechin-3-gallate loaded proliposomal vesicles for management of traumatic brain injury: In-vitro and in-vivo evaluation
- 4 May 2024
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 97
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Epigallocatechin-3-gallate Enhances Cognitive and Memory Performance and Protects Against Brain Injury in Methionine-induced Hyperhomocysteinemia Through Interdependent Molecular PathwaysNeurotoxicity Research, 2022
- Mitochondria-Mediated Moderation of Apoptosis by EGCG in Cytotoxic Neuronal Cells Induced by Lead (Pb) and Amyloid PeptidesBiological Trace Element Research, 2021
- Epigallocatechin-3-gallate improves chronic alcohol-induced cognitive dysfunction in rats by interfering with neuro-inflammatory, cell death and oxido-nitrosative cascadeMetabolic Brain Disease, 2021
- Biomarkers for traumatic brain injury: a short reviewNeurosurgical Review, 2020
- Proliposome powder or tablets for generating inhalable liposomes using a medical nebulizerJournal of Pharmaceutical Investigation, 2020
- Recrystallisation of ferulic acid using the anti-solvent and sonocrystallisation processesJournal of Thermal Analysis and Calorimetry, 2019
- A systematic analysis of Nrf2 pathway activation dynamics during repeated xenobiotic exposureArchives of Toxicology, 2018
- Allyl isothiocyanate attenuates oxidative stress and inflammation by modulating Nrf2/HO-1 and NF-κB pathways in traumatic brain injury in miceMolecular Biology Reports, 2018
- Deletion of Nrf2 Exacerbates Oxidative Stress After Traumatic Brain Injury in MiceCellular and Molecular Neurobiology, 2015
- Protective effect of green tea polyphenol EGCG against neuronal damage and brain edema after unilateral cerebral ischemia in gerbilsJournal of Neuroscience Research, 2004